Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL
To explore the efficiency and safety of CLAG regimen in R/R ALL
Acute Lymphoblastic Leukemia
DRUG: Cladribine|DRUG: Fludarabine
CR (complete remission rate), Response to CLAG regimen., the first cycle (4 weeks)
Overall survival(OS), The time from randomization to death from any cause., From the 1st day to the 365th day after enrollment.|Progression-Free Survival （PFS）, It is defined as the total survival of a patient after CR until the tumor recurrence or death from any cause., From the 1st day to the 365th day after enrollment.
R/R Acute Lymphoblastic Leukemia has poor response to second-line chemotherapy.Here,we want to explore efficiency and safety of CLAG regimen in R/R ALL.